Stay Connected

Sign Up for Updates

We are creating a place where we can share ideas, provide the perspective of America's biopharmaceutical companies and, most importantly, listen to you.

Medicare Monday: Have you heard of CMMI?

By Nicole Longo  |    February 20, 2017
There are a number of acronyms commonly used in the health care world, which can often be confusing and complicated, so this week we’re tackling one of them: CMMI.   Read More

Medicare Monday: How existing CMMI models affect Medicare Part B

By Kelsey Lang  |    November 7, 2016
Earlier this year the Center for Medicare & Medicaid Innovation (CMMI) proposed the Medicare Part B Drug Payment Model, also known as the Part B Demo, an experiment that would change how providers...   Read More

Medicare Monday: Concerns still abound about Part B proposal

By Allyson Funk  |    August 15, 2016
We’ve covered many of the concerns about the government’s overreaching proposal to change Medicare Part B payments and negatively impact seniors’ access to treatment. A lack of patient protections...   Read More

New Report: Part B proposal is more aggressive than previous efforts

By Kelsey Lang  |    June 1, 2016
In the more than 1,300 comments submitted to the Centers for Medicare & Medicaid Services (CMS) on the Part B Drug Payment Model, a wide range of organizations raised concern with the...   Read More

Medicare Monday: What they’re saying about the CMS proposed Part B payment model

By Nicole Longo  |    May 9, 2016
Voices throughout the media and health care system have raised concerns with the Part B Drug Payment Model proposed by the Centers for Medicare & Medicaid Services (CMS). News outlets have called...   Read More

Medicare Monday: Part B proposal lacks essential patient protections

By Kelsey Lang  |    May 2, 2016
We’ve highlighted how the proposed Part B model lacks safeguards to protect patients from barriers and reduced quality of care. Some stakeholders have suggested that the Part B proposal looks a...   Read More

New Research: Access and quality implications of CMS proposed Part B model

By Kelsey Lang  |    April 27, 2016
In recent weeks, providers and stakeholders across the health care system have raised concerns that the Part B Drug Payment Model proposed by the Centers for Medicare & Medicaid Services (CMS) lacks...   Read More

Medicare Monday: 3 things to know about the government’s Medicare payment change

By Allyson Funk  |    March 14, 2016
Last week, the Centers for Medicare & Medicaid Services (CMS) released a proposed demonstration through the Innovation Center to change how Medicare Part B drugs are reimbursed. Here are the three...   Read More

Paying for Personalized Medicine: Protecting the Future of Patient-Centered Cancer Care

By Guest Contributor  |    April 15, 2015
At a time of unprecedented scientific breakthroughs in oncology, personalized medicine is enabling more accurate diagnoses and more targeted treatments, increasing the overall efficiency and...   Read More

Search the Catalyst

View Posts by Topic

see all

Subscribe to Email Updates